Company profile
Agilis Robotics
Agilis Robotics develops miniature flexible robotic instruments for endoluminal surgery. The platform is designed to navigate natural anatomical pathways a...
Facts
- Segment
- SURGICAL
- Country
- China
- Headquarters
- Hong Kong
- Website
- https://www.agilisrobotics.com/
About Agilis Robotics
Agilis Robotics develops miniature flexible robotic instruments for endoluminal surgery. Devices measuring roughly 2.8 to 3.5 millimetres in diameter and up to 1.8 metres long are designed to travel through natural anatomical pathways and reach tumours in the urinary and gastrointestinal tracts.
The system gives surgeons articulated control beyond the reach of conventional rigid tools, supporting removal of early-stage cancers without external incisions. Agilis combines flexible mechanisms, controls and procedure-specific instruments and is advancing the platform through clinical and regulatory development. Commercial availability will depend on clearance for each intended procedure and market.
Market context
DEPLOYMENT
Summary
Type: Surgical robotics company
Core: Flexible endoluminal instruments
Function: Minimally invasive surgery
Audience: Hospitals and surgeons
Products
- Intilume System — surgical_robot
Research, Articles and recent verified events
- Agilis Robotics conducts live two-site Intilume surgical demonstration — 2026-06-23
- Agilis Robotics signs Hong Kong-Jiangsu incubation and investment agreement — 2025-10-20
- Agilis Robotics system wins China Future Healthcare award — 2025-05-13
- Agilis Robotics completes first robot-assisted en-bloc bladder-tumour resection — 2024-12-10
- Agilis Robotics signs Malaysian purchase-cooperation MOU — 2024-09-23
- Agilis Robotics completes cadaver study for bladder-tumour resection — 2024-07-18
- Agilis Robotics receives 2024 Global MedTech Rising Star award — 2024-06-28
- Agilis Robotics completes USD 10 million Series A-plus — 2024-03-20